|
?:authorAffiliation
|
-
[\'Department of Medicine, Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL.\', \'Stanford School of Medicine, Palo Alto, CA.\', \'Seattle Cancer Care, University of Washington, Seattle, WA.\', \'Feinberg School of Medicine, Northwestern University, Chicago, IL.\', \'Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA.\', \'University of Michigan, Rogel Cancer Center, Ann Arbor MI.\', \'Duke Cancer Center, Durham, NC.\', \'Northwell Cancer Institute, Lenox Hill Hospital, New York, NY.\', \'Division of Hematology Oncology, University of Iowa, Iowa City, IA.\', \'MD Anderson Cancer Center, Houston, TX.\', \'Moffitt Cancer Center, Tampa, FL.\', \'Lake Health, University Hospitals, Seidman Cancer Center, Mentor, OH.\', \'University of Washington, Seattle, WA.\', \'Rocky Mountain Cancer Center, Aurora, CO.\', \'Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA.\', \'The Center for Cancer and Blood Disorders, Fort Worth, TX.\', \'Advanced Oncology Nursing Resources, Phoenix, AZ.\', \'Stanford Health Care, Palo Alto, CA.\', \'Kaiser Permanente, Northern California (NCAL), Oakland, CA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}